Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization

Yao, Wei, Cheng, Zhiqiang, Pham, Aaron, Busse, Cheryl, Zimmermann, Elizabeth A., Ritchie, Robert O., Lane, Nancy E.·2008·Arthritis & Rheumatism
DOI 10.1002/art.23954

Cited by (128)

Items 101–128 of 128

  1. Bone histomorphometry in rodents
    Yanfei Linda Ma, David B. Burr, Reinhold G. Erben · 2019 · Elsevier eBooks
  2. An overview of animal models induced by glucocorticoids
    Azadeh Mesripour, Mansooreh Asghari-Varzaneh, Leila Safaeian · 2023 · Physiology and Pharmacology
  3. Moderate Zinc Supplementation During Prolonged Steroid Therapy Exacerbates Bone Loss in Rats
    Rozy Kamal, Subhash Chand Bansal, Niranjan K. Khandelwal, D. V., Devinder Kumar Dhawan · 2014 · Biological Trace Element Research
  4. RETRACTED: An MSC bone‐homing compound, Rab001, increases bone mass and reduces the incidence of osteonecrosis in a glucocorticoid‐induced osteonecrosis mouse model
    Min Jiang, Lixian Liu, Xuexiang Xiang, Runmin Liang, Xuelian Qin, Jinmin Zhao, Qingjun Wei · 2020 · Clinical and Experimental Pharmacology and Physiology · Retracted
  5. Vía Wnt y esclerostina como nuevas dianas para la evaluación y el tratamiento de la osteoporosis
    Guillermo Alonso, Antonia García‐Martin, Manuel Muñoz‐Torres · 2012 · Medicina Clínica
  6. Basics of Bone Biology
    Martina Rauner, Lorenz Christian Hofbauer · 2016 · Springer eBooks
  7. Recent advances in models for screening potential osteoporosis drugs
    Daniela Merlotti, Maria Materozzi, Tommaso Picchioni, Simone Bianciardi, Mario Alessandri, Ranuccio Nuti, Luigi Gennari · 2018 · Expert Opinion on Drug Discovery
  8. Inhibiting the NLRP3 inflammasome pathway: An effective way to treat chronic inflammation in experimental autoimmune uveitis
    Avik Shome, Odunayo Omolola Mugisho, Priyanka Agarwal, Rachael Louise Niederer, Ilva D. Rupenthal · 2025 · European Journal of Pharmacology
  9. Acute and subchronic co-administrations to cadmium, diazinon and selenium induce apparent osteoporotic symptoms in adult male rats
    Hana Ďúranová, Monika Martiniaková, Ivana Boboňová, Radoslav Omelka, Robert Stawarz, Robert Toman · 2014 · Biologia
  10. MARKERS OF BONE TURNOVER IN PRECLINICAL DEVELOPMENT OF DRUGS FOR SKELETAL DISEASES
    Jukka P. Rissanen · 2013 · UTUPub (University of Turku)
  11. Zebrafish scales in bone research
    Erik de Vrieze · 2014
  12. In Utero Sources of Skeletal Variation: the Role of Maternal Prenatal Stress
    Sarah K. Amugongo · 2010 · eScholarship (California Digital Library)
  13. Avaliação do consumo alimentar e da densidade mineral óssea de crianças com dermatite atópica
    Vanessa Ramos Alves Penterich · 2011
  14. Review Developments in the scientific understanding of osteoporosis
    Nancy E. Lane, Wei Yao · 2009
  15. GLUCOCORTICOID INDUCED OSTEOPOROSIS Review Article
    David Banji · 2010
  16. Bone mineral density in children with moderate or severe atopic dermatitis
    Ariana Campos Yang, Vanessa Ramos Alves Penterich, Rosa Maria Rodrigues Pereira, Liliam Takayama, Marise Lazaretti‐Castro, Jorge Elias Kalil, Fábio Fernandes Morato Castro · 2013 · Brazilian Journal of Allergy and Immunology (BJAI)
  17. Glucocorticoid induced osteoporosis and mechanisms of intervention
    Amy Y. Sato · 2017 · IUScholarWorks (Indiana University)
  18. Clinical and basic research papers – November 2008
    Serge Ferrari, Ego Seeman, Hong‐Wen Deng, David Graham Little, Toshio Matsumoto · 2008 · IBMS BoneKEy
  19. Role of Wnt/β-catenin and CXCL12/CXCR4 signalling axes in the damage and recovery of the bone marrow microenvironment following methotrexate chemotherapy.
    Kristen R. Georgiou · 2011 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  20. A Cellular Comparison of Bone Inductive Properties of Trabecular Metal vs Titanium in Healthy and Osteopenia/Osteoporosis Subjects
    Campbell, Elizabeth · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  21. THE EFFECTIVENESS OF ZINC AND RISEDRONATE ON BONE TURNOVER IN RAT MODEL OF OSTEOPOROSIS ASSESSED WITH THE EXPRESSION OF β-CROSSLAPS
    Adam Fajar, Mohammad Rizal Chaidir, Dicky Mulyadi, Ahmad Ramdan, Yoyos Dias Ismiarto · 2019 · (JOINTS) Journal Orthopaedi and Traumatology Surabaya
  22. Effect of Teripratide and Alendronate on Spinal Fusion in Rats with Glucocorticoid: Induced Osteoporosis
    Mohamed El-Sayed Mahmoud · 2021 · Clinical and Experimental Pharmacology
  23. Laboratory Directed Research and Development Program FY 2008 Annual Report
    Todd C Hansen editor · 2009
  24. Regulation of Wnt Signaling Pathway by Costic Acid Derivative, An Efficient Strategy for Treatment of Glucocorticoid‐Induced Osteoporosis in Rat Model
    Xue Ru Jiang, Xiangying Kong · 2023 · ChemistrySelect
  25. Sclerostin - The silent bone breaker
    Kandasamy Roshni, Neetha J. Shetty, Deepa G Kamath · 2023 · Cumhuriyet Dental Journal
  26. A polymeric dexamethasone prodrug attenuates focal segmental glomerulosclerosis (FSGS) in an Adriamycin-induced mouse model with minimal glucocorticoid side effects
    Hui‐di Jiang, Xin Fu, Salma Althobaiti, Braeden R. Pinkerton, Shabnam Arash, Xiaoqing Du, Zhenshan Jia, Fang Yu, Kirk W. Foster, Geoffrey M. Thiele et al. · 2025 · Smart Materials in Medicine
  27. Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review
    Elena A. Tsourdi, Ulrike Baschant, Martina Rauner, Hanna Taipaleenmäki, Elizabeth Martha Winter · 2025 · Drugs & Aging
  28. Osteocytes in Mechanosensing: Insights from Mouse Models and Human Patients
    Ken Watanabe, Kyoji Ikeda · 2010 · Springer eBooks